Erratum to Giangrande et al. "Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A" (Thromb Haemost 2017; 117: 252-261)
- PMID: 31117130
- DOI: 10.1055/s-0039-1692336
Erratum to Giangrande et al. "Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A" (Thromb Haemost 2017; 117: 252-261)
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Erratum for
-
Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A.Thromb Haemost. 2017 Jan 26;117(2):252-261. doi: 10.1160/TH16-06-0444. Epub 2016 Dec 1. Thromb Haemost. 2017. PMID: 27904904 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
